The American Society of Clinical Oncology (ASCO), took place in Chicago, May 31st – June 4th, 2024. We were present at our partner Personalis’ booth #30149. If you missed us, contact us to learn more about how our proprietary, non-invasive 5hmC epigenomic platform Virtuoso can help you improve your drug-developing process by:
– Helping identify patients more likely to benefit from the drug treatment
-Monitoring response through the treatment cycle
– Gaining insights about the underlying mechanisms associated with the response to the drug
